Sequent Scienti is not listed on NSE
AnnouncementsSequent Scientific: Change in designation of director
AnnouncementsSequent Scientific: Updates on outcome of AGM
AnnouncementsSequent Scientific allots 15,04,800 equity shares
AnnouncementsSequent Scientific allots 852700 equity shares
AnnouncementsSequent Scientific & Shasun Pharmaceuticals announce JV
AnnouncementsSequent Scientific; Allotment of equity shares
AnnouncementsSequent Scientific promotes Gautam Kumar Das as Joint MD
AnnouncementsSequent Scientific to consider dividend
AnnouncementsSequent Scientific receives USFDA approval
|Company Name||Last Price||%
|Dr Reddys Labs||2450.80||0.05||2545.00||1764.00||41,688.04|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Sequent Scienti is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 362.81 crore.The company has reported a consolidated sales of Rs 28.35 crore and a Net Profit of Rs 1.52 crore for the quarter ended Sep 2008.
The company management includes K R Ravishankar - Director, Gautam Kumar Das - Joint Managing Director, Gopakumar Gopalan Nair - Independent Director, Kannan Ramanujam - Independent Director.
It is listed on the BSE with a BSE Code of 512529.
Its Registered office is at '301, 'Dosti Pinnacle', 3rd Floor,' Plot No. E7, Road No. 22,,Wagle Indl. Estate. Thane,Maharashtra - 400604.
Their Registrars are Adroit Corporate Service (P) Ltd.